US PRE-MARKET MOVERS: INTC, AAPL, HZO, TSM, SION, META, GME, HPE, VRSK

A standard pre-market movers sheet, and the pattern is the familiar one: the index futures are flat while single-stock catalysts do all the work, which is typical of sessions where the tape is driven by idiosyncratic news flow rather than macro. The distinct mechanisms matter here. INTC's proposed common stock raise is a dilution story, and large primary offerings from issuers with heavy capital requirements have historically traded down toward or through the expected offer discount until pricing clears, with the size of the deal relative to the existing float the key tell. HZO is the clean cash takeout, and in these situations the spread to the cash consideration is the trade, governed by financing conditionality and the buyer's track record of closing. SION's collapse on a failed mid-stage endpoint is the standard biotech binary outcome, where a discontinued programme typically leaves the stock to re-rate on remaining pipeline and cash runway rather than any recovery in the failed asset. VRSK is the less common case: a court compelling a buyer to complete an acquisition it appears to want out of, a setup that in past contested-deal episodes has weighed on the acquirer while the market recalibrates the combined entity's economics. AAPL's downgrade, built on memory cost pressure and EPS cuts, fits the recurring pattern where component-cost squeezes on hardware names compress gross margin before they show in revenue. Worth noting that pre-market moves of this kind frequently retrace a portion at the open as full liquidity arrives, particularly in the names driven by ratings changes rather than hard news.